FDA.reportPublic FDA data

rivastigmine 13.3 MG/Day 24HR Transdermal Patch

RxCUI
1308569
RxNorm name
rivastigmine 13.3 MG/Day 24HR Transdermal Patch
Display name
rivastigmine 13.3 MG/Day 24HR Transdermal Patch
Full name
rivastigmine 13.3 MG/Day 24HR Transdermal Patch
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:00

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 12 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
RivastigmineRIVASTIGMINEZydus Lifesciences Limited966d59ea-5cea-4fef-8b96-e0efe885caf42025-11-17Exact identifier
rxcui: 1308569
RivastigmineRIVASTIGMINENorthstar Rx LLC.8b809739-8381-4cc1-ab4a-5b17ab902a3d2025-11-14Warnings, Adverse reactionsExact identifier
rxcui: 1308569
Rivastigmine Transdermal SystemRIVASTIGMINEBryant Ranch Prepack8d8823c0-9339-4ec8-8a19-d13974b6614b2025-04-01Warnings, Adverse reactionsExact identifier
rxcui: 1308569
Rivastigmine Transdermal SystemRIVASTIGMINEBryant Ranch Prepack5cd5c434-ffd0-4aed-9eba-145c86b115bb2025-03-27Warnings, Adverse reactionsExact identifier
rxcui: 1308569
Rivastigmine Transdermal SystemRIVASTIGMINEBryant Ranch Prepack6cc286d9-c5d4-4505-83bb-9015e30778512025-03-19Warnings, Adverse reactionsExact identifier
rxcui: 1308569
Rivastigmine Transdermal SystemRIVASTIGMINEBreckenridge Pharmaceutical, Inc.b201fe68-b5e5-4a6f-8cf1-069543f03e762025-01-15Warnings, Adverse reactionsExact identifier
rxcui: 1308569
RivastigmineRIVASTIGMINEMylan Pharmaceuticals Inc.4ab335d1-19ee-4cd9-9776-8086645d19e42024-09-21Warnings, Adverse reactionsExact identifier
rxcui: 1308569
RivastigmineRIVASTIGMINEAmneal Pharmaceuticals LLC8b671fc9-8cb0-4406-a9ee-7c95086d62002024-07-02Warnings, Adverse reactionsExact identifier
rxcui: 1308569
RivastigmineRIVASTIGMINEZydus Pharmaceuticals USA Inc.64dad603-2389-456b-8c18-d1d40b7e74192024-05-27Warnings, Adverse reactionsExact identifier
rxcui: 1308569
RivastigmineRIVASTIGMINESandoz Inc92a58ebb-748d-49f4-bf11-ecbcf54241522024-05-08Warnings, Adverse reactionsExact identifier
rxcui: 1308569
ExelonRIVASTIGMINENovartis Pharmaceuticals Corporation07c12e14-bbd5-4ec8-84e4-fbe7b5ba10e02024-05-08Warnings, Adverse reactionsExact identifier
rxcui: 1308569
ExelonRIVASTIGMINESandoz Incb6ed6d15-116d-4596-92ce-3414574d7ba02024-05-08Warnings, Adverse reactionsExact identifier
rxcui: 1308569

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 13 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
5cd5c434-ffd0-4aed-9eba-145c86b115bbrivastigmine 13.3 MG/Day 24HR Transdermal System [PSN] · 24 HR rivastigmine 0.554 MG/HR Transdermal System [SCD] · rivastigmine 13.3 MG/Day 24HR Transdermal Patch [SY] · rivastigmine 13.3 MG/Day 24HR Transdermal System [SY]4111These highlights do not include all the information needed to use RIVASTIGMINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for RIVASTIGMINE TRANSDERMAL SYSTEM. RIVASTIGMINE transdermal system Initial U.S. Approval: 200020250327
6cc286d9-c5d4-4505-83bb-9015e3077851rivastigmine 13.3 MG/Day 24HR Transdermal System [PSN] · 24 HR rivastigmine 0.554 MG/HR Transdermal System [SCD] · rivastigmine 13.3 MG/Day 24HR Transdermal Patch [SY] · rivastigmine 13.3 MG/Day 24HR Transdermal System [SY]4106These highlights do not include all the information needed to use RIVASTIGMINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for RIVASTIGMINE TRANSDERMAL SYSTEM. RIVASTIGMINE transdermal system Initial U.S. Approval: 200020250319
8d8823c0-9339-4ec8-8a19-d13974b6614brivastigmine 13.3 MG/Day 24HR Transdermal System [PSN] · 24 HR rivastigmine 0.554 MG/HR Transdermal System [SCD] · rivastigmine 13.3 MG/Day 24HR Transdermal Patch [SY] · rivastigmine 13.3 MG/Day 24HR Transdermal System [SY]4102These highlights do not include all the information needed to use RIVASTIGMINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for RIVASTIGMINE TRANSDERMAL SYSTEM. RIVASTIGMINE transdermal system Initial U.S. Approval: 200020250401
07c12e14-bbd5-4ec8-84e4-fbe7b5ba10e0rivastigmine 13.3 MG/Day 24HR Transdermal System [PSN] · 24 HR rivastigmine 0.554 MG/HR Transdermal System [SCD] · rivastigmine 13.3 MG/Day 24HR Transdermal Patch [SY] · rivastigmine 13.3 MG/Day 24HR Transdermal System [SY]430These highlights do not include all the information needed to use EXELON PATCH safely and effectively. See full prescribing information for EXELON PATCH. EXELON ® PATCH (rivastigmine transdermal system) Initial U.S. Approval: 200020240508
8b671fc9-8cb0-4406-a9ee-7c95086d6200rivastigmine 13.3 MG/Day 24HR Transdermal System [PSN] · 24 HR rivastigmine 0.554 MG/HR Transdermal System [SCD] · rivastigmine 13.3 MG/Day 24HR Transdermal Patch [SY] · rivastigmine 13.3 MG/Day 24HR Transdermal System [SY]417These highlights do not include all the information needed to use RIVASTIGMINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for RIVASTIGMINE TRANSDERMAL SYSTEM. RIVASTIGMINE transdermal system Initial U.S. Approval: 200020240702
4ab335d1-19ee-4cd9-9776-8086645d19e4rivastigmine 13.3 MG/Day 24HR Transdermal System [PSN] · 24 HR rivastigmine 0.554 MG/HR Transdermal System [SCD] · rivastigmine 13.3 MG/Day 24HR Transdermal Patch [SY] · rivastigmine 13.3 MG/Day 24HR Transdermal System [SY]410These highlights do not include all the information needed to use RIVASTIGMINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for RIVASTIGMINE TRANSDERMAL SYSTEM. RIVASTIGMINE transdermal system Initial U.S. Approval: 200020240921
8b809739-8381-4cc1-ab4a-5b17ab902a3drivastigmine 13.3 MG/Day 24HR Transdermal System [PSN] · 24 HR rivastigmine 0.554 MG/HR Transdermal System [SCD] · rivastigmine 13.3 MG/Day 24HR Transdermal Patch [SY] · rivastigmine 13.3 MG/Day 24HR Transdermal System [SY]47These highlights do not include all the information needed to use RIVASTIGMINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for RIVASTIGMINE TRANSDERMAL SYSTEM. Rivastigmine Transdermal System Initial U.S. Approval: 200020251114
b201fe68-b5e5-4a6f-8cf1-069543f03e76rivastigmine 13.3 MG/Day 24HR Transdermal System [PSN] · 24 HR rivastigmine 0.554 MG/HR Transdermal System [SCD] · rivastigmine 13.3 MG/Day 24HR Transdermal Patch [SY] · rivastigmine 13.3 MG/Day 24HR Transdermal System [SY]47These highlights do not include all the information needed to use RIVASTIGMINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for RIVASTIGMINE TRANSDERMAL SYSTEM. RIVASTIGMINE transdermal system Initial U.S. Approval: 200020250115
92a58ebb-748d-49f4-bf11-ecbcf5424152rivastigmine 13.3 MG/Day 24HR Transdermal System [PSN] · 24 HR rivastigmine 0.554 MG/HR Transdermal System [SCD] · rivastigmine 13.3 MG/Day 24HR Transdermal Patch [SY] · rivastigmine 13.3 MG/Day 24HR Transdermal System [SY]45These highlights do not include all the information needed to use RIVASTIGMINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for RIVASTIGMINE TRANSDERMAL SYSTEM. RIVASTIGMINE TRANSDERMAL SYSTEM Initial U.S. Approval: 200020240508
64dad603-2389-456b-8c18-d1d40b7e7419rivastigmine 13.3 MG/Day 24HR Transdermal System [PSN] · 24 HR rivastigmine 0.554 MG/HR Transdermal System [SCD] · rivastigmine 13.3 MG/Day 24HR Transdermal Patch [SY] · rivastigmine 13.3 MG/Day 24HR Transdermal System [SY]44These highlights do not include all the information needed to use RIVASTIGMINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for RIVASTIGMINE TRANSDERMAL SYSTEM. Rivastigmine Transdermal System Initial U.S. Approval: 200020240527
7d8414f5-b51f-4ccb-b7a1-83b9ede5b266rivastigmine 13.3 MG/Day 24HR Transdermal System [PSN] · 24 HR rivastigmine 0.554 MG/HR Transdermal System [SCD] · rivastigmine 13.3 MG/Day 24HR Transdermal Patch [SY] · rivastigmine 13.3 MG/Day 24HR Transdermal System [SY]43These highlights do not include all the information needed to use RIVASTIGMINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for RIVASTIGMINE TRANSDERMAL SYSTEM. Rivastigmine Transdermal System Initial U.S. Approval: 200020221004
966d59ea-5cea-4fef-8b96-e0efe885caf4rivastigmine 13.3 MG/Day 24HR Transdermal System [PSN] · 24 HR rivastigmine 0.554 MG/HR Transdermal System [SCD] · rivastigmine 13.3 MG/Day 24HR Transdermal Patch [SY] · rivastigmine 13.3 MG/Day 24HR Transdermal System [SY]41Rivastigmine Transdermal System20251117
b6ed6d15-116d-4596-92ce-3414574d7ba0rivastigmine 13.3 MG/Day 24HR Transdermal System [PSN] · 24 HR rivastigmine 0.554 MG/HR Transdermal System [SCD] · rivastigmine 13.3 MG/Day 24HR Transdermal Patch [SY] · rivastigmine 13.3 MG/Day 24HR Transdermal System [SY]41These highlights do not include all the information needed to use EXELON PATCH safely and effectively. See full prescribing information for EXELON PATCH. EXELON ® PATCH (rivastigmine transdermal system) Initial U.S. Approval: 200020240508